Zydus gets US FDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg
Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus
Lupin, Zydus sign licensing pact to co-market Saroglitazar Mg for chronic liver diseases in India
In 2020, Saroglitazar Mg received approval for the treatment of NASH and NAFLD
Zydus Lifesciences acquires 6.5 per cent stake in Mylab Discovery Solutions
The acquisition represents collective vision to transform healthcare by combining therapeutic expertise in human formulations and…
USFDA concludes inspection at Zydus’ Ahmedabad facility
The cGMP inspection concluded with nil observations
Zydus receives USFDA approval for Metoprolol Tartrate Tablets USP, 25 mg, 50 mg, and 100 mg
Metoprolol belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in…
Zydus in-licenses critical drug for CKD patients from Pharmacosmos
MonoFerric is indicated for the treatment of iron deficiency in adult patients when oral iron preparations are ineffective or…
Zydus receives final approval from US FDA for Dapagliflozin tablets
Dapagliflozin is used with a proper diet and an exercise programme to control high blood sugar in people with type-II diabetes
Zydus gets 180 days’ shared exclusivity for Roflumilast tablets
Zydus’ Roflumilast tablets are indicated as a treatment to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD)…
Zydus posts consolidated revenues of Rs 3,655 crores in Q3
Earnings before Interest, Depreciation and Tax (EBIDTA) stood at Rs 753 crores and net profit for the quarter stood at Rs 500…
Zydus supplies the first consignment of its COVID-19 vaccine ZyCoV-D
ZyCoV-D is a three-dose vaccine administered intradermally using the painless PharmaJet needle-free system, Tropis, on day zero,…